86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details
臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04908397 (ClinicalTrials.gov) | September 29, 2021 | 17/5/2021 | Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension | Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension;Familial Primary Pulmonary Hypertension;Primary Pulmonary Hypertension;Lung Diseases;Carnitine Nutritional Deficiency | Dietary Supplement: L-carnitine | Vanderbilt University Medical Center | NULL | Recruiting | 18 Years | 85 Years | All | 12 | Phase 1 | United States |